Are GLP-1 agonists recommended prior to conception to reduce adverse pregnancy outcomes in women with diabetes or obesity?
Abstract
Current guidelines advise against the use of GLP-1 receptor agonists prior to conception due to potential risks and insufficient evidence supporting their safety or efficacy in reducing adverse pregnancy outcomes.
Fields of Study & Subjects
Pregnancy and Medication Impact
Gestational Diabetes Research and Management
Diabetes Treatment and Management
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 January 2026